Eribulin versus dacarbazine in previously treated patients with advanced liposarcoma or leiomyosarcoma: a randomised, open-label, multicentre, phase 3 trial

2016755 citationsJournal Articlegreen Open Access

Authors

Partnerships for the goals

Published in: The Lancet

Volume 387, Issue 10028, pp. 1629-1637

Field-Weighted Citation Impact: 78.82